Christian Monnerat

877 total citations
34 papers, 645 citations indexed

About

Christian Monnerat is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christian Monnerat has authored 34 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christian Monnerat's work include BRCA gene mutations in cancer (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Genetic factors in colorectal cancer (6 papers). Christian Monnerat is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Genetic factors in colorectal cancer (6 papers). Christian Monnerat collaborates with scholars based in Switzerland, France and United States. Christian Monnerat's co-authors include Sandrine Faivre, Éric Raymond, Thierry Le Chevalier, Serge Leyvraz, Michael C. Perry, Roger Stupp, Andrew T. Turrisi, Silvia Novello, Stéphane Temam and Jean Bourhis and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Christian Monnerat

31 papers receiving 624 citations

Peers

Christian Monnerat
Carla M. van Herpen Netherlands
Peter Moosmann Switzerland
Ivan Ngai United States
Renske Fles Netherlands
Lode Goethals Belgium
Isao Miyazaki Japan
Matthew E. Witek United States
Zhibin Cheng China
Yih‐Lin Chung Taiwan
Carla M. van Herpen Netherlands
Christian Monnerat
Citations per year, relative to Christian Monnerat Christian Monnerat (= 1×) peers Carla M. van Herpen

Countries citing papers authored by Christian Monnerat

Since Specialization
Citations

This map shows the geographic impact of Christian Monnerat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Monnerat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Monnerat more than expected).

Fields of papers citing papers by Christian Monnerat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Monnerat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Monnerat. The network helps show where Christian Monnerat may publish in the future.

Co-authorship network of co-authors of Christian Monnerat

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Monnerat. A scholar is included among the top collaborators of Christian Monnerat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Monnerat. Christian Monnerat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ming, Chang, Günther Fink, Nicole Bürki, et al.. (2022). Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort. Journal of Personalized Medicine. 12(10). 1740–1740. 9 indexed citations
3.
Schwendinger, Peter J. & Christian Monnerat. (2022). Antoine Senglet (10.IX.1927 - 29.III.2015), a little-known Swiss entomologist and arachnologist. Revue suisse de zoologie. 129(1). 2 indexed citations
4.
Rudaz, Myriam, Nicole Bürki, Pierre O. Chappuis, et al.. (2021). Bottom-up approach: soliciting participants’ input for developing a digital platform to support cancer coping and family communication about hereditary cancer risks in Switzerland and Korea. 1 indexed citations
5.
Fadda, Marta, Pierre O. Chappuis, Maria C. Katapodi, et al.. (2020). Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?. PLoS ONE. 15(10). e0240054–e0240054. 5 indexed citations
6.
Chappuis, Pierre O., Nicole Bürki, Katharina Buser, et al.. (2017). Genetic predisposition to breast and ovarian cancer. Schweizerische Ärztezeitung. 98(2122). 682–684. 4 indexed citations
7.
Chappuis, Pierre O., Nicole Bürki, K. Buser, et al.. (2017). Genetic predisposition to breast and ovarian cancer. Bulletin des Médecins Suisses. 98(2122). 682–684. 4 indexed citations
8.
Balmelli, Cathrin, Michael Mark, Christian Spirig, et al.. (2014). Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations. memo - Magazine of European Medical Oncology. 7(3). 181–186.
9.
Zufferey, Maria Caiata, Olivia Pagani, Monica Taborelli, et al.. (2014). Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations. Genetics in Medicine. 17(9). 726–732. 13 indexed citations
10.
Ferrarini, Alberto, Alessia Pica, Karl Heinimann, et al.. (2011). Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53. Familial Cancer. 10(2). 187–192. 13 indexed citations
11.
Monnerat, Christian, Agnès Chompret, Caroline Kannengiesser, et al.. (2007). BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma. Familial Cancer. 6(4). 453–461. 30 indexed citations
12.
Monnerat, Christian & Thierry Le Chevalier. (2006). Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Annals of Oncology. 17. v86–v90. 15 indexed citations
13.
Vernez, Maxime, et al.. (2006). A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene. Familial Cancer. 6(1). 141–145. 11 indexed citations
14.
Pétignat, Christiane, Aline Wenger, K. Zaman, et al.. (2004). Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?. European Journal of Clinical Microbiology & Infectious Diseases. 23(10). 751–758. 17 indexed citations
15.
Stupp, Roger, Christian Monnerat, Andrew T. Turrisi, Michael C. Perry, & Serge Leyvraz. (2004). Small cell lung cancer: state of the art and future perspectives. Lung Cancer. 45(1). 105–117. 135 indexed citations
16.
Monnerat, Christian, Roger Henriksson, Thierry Le Chevalier, et al.. (2004). Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer. Annals of Oncology. 15(2). 316–323. 57 indexed citations
17.
Monnerat, Christian, Thierry Le Chevalier, Karen Kelly, et al.. (2004). Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(16). 5439–5446. 41 indexed citations
18.
Sessa, Cristiana, C. Cuvier, S. Caldiera, et al.. (2002). Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors. Annals of Oncology. 13(7). 1140–1150. 37 indexed citations
19.
Monnerat, Christian, Sandrine Faivre, Stéphane Temam, Jean Bourhis, & Éric Raymond. (2002). End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Annals of Oncology. 13(7). 995–1006. 81 indexed citations
20.
Faivre, Sandrine, Thierry Le Chevalier, Christian Monnerat, et al.. (2002). Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma. Annals of Oncology. 13(9). 1479–1489. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla M. van Herpen Breakdown of academic impact, for papers by Peter Moosmann Breakdown of academic impact, for papers by Ivan Ngai Breakdown of academic impact, for papers by Renske Fles Breakdown of academic impact, for papers by Lode Goethals Breakdown of academic impact, for papers by Isao Miyazaki Breakdown of academic impact, for papers by Matthew E. Witek Breakdown of academic impact, for papers by Zhibin Cheng Breakdown of academic impact, for papers by Yih‐Lin Chung
Rankless by CCL
2026